Healthcare - Biotechnology - NASDAQ - NL
$ 46.58
-6.2 %
$ 3.19 B
Market Cap
-11.56
P/E
BALANCE SHEET
458 M
ASSETS
102 M
LIABILITIES
356 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Merus N.V.
| Current Assets | 369 M |
| Cash & Short-Term Investments | 355 M |
| Receivables | 3.98 M |
| Other Current Assets | 9.66 M |
| Non-Current Assets | 89.7 M |
| Long-Term Investments | 57.3 M |
| PP&E | 23.5 M |
| Other Non-Current Assets | 8.87 M |
| Current Liabilities | 69.1 M |
| Accounts Payable | 4.6 M |
| Short-Term Debt | 1.67 M |
| Other Current Liabilities | 62.8 M |
| Non-Current Liabilities | 33.1 M |
| Long-Term Debt | 10.5 M |
| Other Non-Current Liabilities | 22.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash & Cash Equivalents | 205.0 | 147.7 | 241.4 | 163.1 | 197.6 | 164.4 | 179.6 | 59.9 | 35.9 | 2.2 | 14.7 | 7.8 |
| Short Term Investments | 150.1 | 142.5 | 169.0 | 44.7 | 42.2 | 51.3 | 40.8 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.0 | 4.7 | 6.7 | 1.7 | 2.9 | 2.9 | 3.8 | 0.2 | 0 | 0.7 | 1.0 | 1.3 |
| Inventory | 0 | 9.3 | 4.9 | 7.4 | 1 | (3.2) | 1 | 12.5 | 0 | 2 | 1 | 0 |
| Other Current Assets | 9.7 | 11.5 | 7.1 | 8.5 | 4.7 | 4.5 | 3.0 | 12.8 | 2.9 | 0.7 | 0.7 | 0 |
| Total Current Assets | 368.8 | 306.4 | 424.2 | 218.0 | 247.4 | 223.8 | 225.7 | 74.8 | 37.7 | 3.3 | 15.8 | 9.1 |
| PP&E | 23.5 | 24.8 | 7.3 | 8.0 | 8.9 | 2.8 | 1.4 | 0.7 | 0.4 | 0.4 | 0.5 | 0.7 |
| Intangible Assets | 1.8 | 1.9 | 2.3 | 2.8 | 2.9 | 2.8 | 0.4 | 0.4 | 0.5 | 0.6 | 0.8 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 57.3 | 36.5 | 20.3 | 0 | 2.0 | 19.4 | 8.5 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 5.9 | 4.8 | 2.1 | 1.9 | 1.9 | 1.2 | 0.2 | 0.2 | 0.2 | 0 | 1 | 1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1.05 K | 1 | 1 | 0 | 0 |
| Total Assets | 458.5 | 376.5 | 456.6 | 231.2 | 263.4 | 250.0 | 236.1 | 76.0 | 38.8 | 4.3 | 17.2 | 10.6 |
| LIABILITIES | ||||||||||||
| Accounts Payable | 4.6 | 9.8 | 13.2 | 3.1 | 3.0 | 3.2 | 3.4 | 2.3 | 2.4 | 2.4 | 1.3 | 0.3 |
| Short Term Debt | 1.7 | 1.7 | 1.5 | 1.4 | 1.4 | 0 | 0 | 2.0 | 0.2 | 0.2 | 0.2 | 0.2 |
| Other Current Liabilities | 38.5 | 35.6 | 22.5 | 21.8 | 13.5 | 10.1 | 10.1 | 5.4 | 2.5 | 2.8 | 1.5 | 1.3 |
| Total Current Liabilities | 69.1 | 78.9 | 71.9 | 46.7 | 36.8 | 33.1 | 22.5 | 8.2 | 6.9 | 7.1 | 5.4 | 2.0 |
| Long Term Debt | 10.5 | 11.8 | 2.3 | 2.5 | 3.9 | 0 | 0 | 0.3 | 0.5 | 0.8 | 1.1 | 1.3 |
| Deferred Tax Income | 3.0 | 3.4 | 1.1 | 1.1 | 1.3 | 0 | 0 | 0.000001 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Total Liabilities | 102.2 | 129.5 | 140.4 | 129.0 | 132.1 | 144.9 | 178.7 | 40.3 | 7.9 | 8.6 | 6.6 | 3.3 |
| EQUITY | ||||||||||||
| Common Stock | 5.9 | 4.8 | 4.5 | 3.2 | 2.9 | 2.4 | 2.1 | 1.5 | 0.8 | 0.3 | 0.3 | 0.2 |
| Retained Earnings | (753.1) | (598.1) | (466.9) | (400.1) | (314.6) | (200.3) | (200.9) | (112.8) | (69.3) | (49.6) | (32.5) | (18.7) |
| Other Accumulative Comprehensive Income/Loss | (22.5) | (30.4) | (9.2) | 9.1 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 356.3 | 247.1 | 316.2 | 102.3 | 131.3 | 105.1 | 57.5 | 35.8 | 30.9 | (4.3) | 10.6 | 7.3 |
| Total Liabilities and Equity | 458.5 | 376.5 | 456.6 | 231.2 | 263.4 | 250.0 | 236.1 | 76.0 | 38.8 | 4.3 | 17.2 | 10.6 |
| SHARES OUTSTANDING | ||||||||||||
| Common Shares Outstanding | 51.6 | 44.9 | 38.6 | 29.3 | 24.2 | 22.3 | 19.2 | 13.2 | 15.4 | 15.4 | 15.4 |